Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (101-110 of 253) with videos related to

Pageof 26
Sort By:
Journal of Neuro-Oncology|July 10, 2012
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysisAndré O von Bueren, Joachim Gerss, Christian Hagel, et al.
Neuro-Oncology|December 29, 2021
Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg StudySarah Peters, Julien Merta, Laura Schmidt, et al.
Glia|March 1, 2012
Proper cerebellar development requires expression of β1-integrin in Bergmann glia, but not in granule neuronsAlexandra Frick, Daniel Grammel, Felix Schmidt, et al.
Pediatric Blood & Cancer|November 30, 2010
Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapsesAndré O von Bueren, Monika Warmuth-Metz, Paul G Schlegel, et al.
Journal of Neuro-Oncology|January 11, 2014
Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocolCarsten Friedrich, Klaus Müller, Katja von Hoff, et al.
Neuro-Oncology|December 30, 2023
Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettesMatthias Dottermusch, Ali Biabani, Tasja Lempertz, et al.
Acta Neuropathologica|October 1, 2022
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomasTobias Goschzik, Martin Mynarek, Evelyn Doerner, et al.
Genes, Chromosomes & Cancer|June 27, 2007
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomasStefan Pfister, Marc Remke, Grischa Toedt, et al.
Oncotarget|October 1, 2015
Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trialSteven C Clifford, Birgitta Lannering, Ed C Schwalbe, et al.
BMC Infectious Diseases|May 27, 2008
Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and SwitzerlandArne Simon, Roland A Ammann, Udo Bode, et al.
Pageof 26

Showing results (101-110 of 253) with videos related to

Sort By:
Pageof 26
Journal of Neuro-Oncology|July 10, 2012
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysisAndré O von Bueren, Joachim Gerss, Christian Hagel, et al.
Neuro-Oncology|December 29, 2021
Evaluation of dose, volume, and outcome in children with localized, intracranial ependymoma treated with proton therapy within the prospective KiProReg StudySarah Peters, Julien Merta, Laura Schmidt, et al.
Glia|March 1, 2012
Proper cerebellar development requires expression of β1-integrin in Bergmann glia, but not in granule neuronsAlexandra Frick, Daniel Grammel, Felix Schmidt, et al.
Pediatric Blood & Cancer|November 30, 2010
Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapsesAndré O von Bueren, Monika Warmuth-Metz, Paul G Schlegel, et al.
Journal of Neuro-Oncology|January 11, 2014
Adults with CNS primitive neuroectodermal tumors/pineoblastomas: results of multimodal treatment according to the pediatric HIT 2000 protocolCarsten Friedrich, Klaus Müller, Katja von Hoff, et al.
Neuro-Oncology|December 30, 2023
Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettesMatthias Dottermusch, Ali Biabani, Tasja Lempertz, et al.
Acta Neuropathologica|October 1, 2022
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomasTobias Goschzik, Martin Mynarek, Evelyn Doerner, et al.
Genes, Chromosomes & Cancer|June 27, 2007
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomasStefan Pfister, Marc Remke, Grischa Toedt, et al.
Oncotarget|October 1, 2015
Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trialSteven C Clifford, Birgitta Lannering, Ed C Schwalbe, et al.
BMC Infectious Diseases|May 27, 2008
Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and SwitzerlandArne Simon, Roland A Ammann, Udo Bode, et al.
Pageof 26